Clinical Science Director PCI biotech, previously Ass Prof and PI at Karolinska Institute. Focus on immunotherapy and immune oncology. Opinions are my own.
Screen of 2,025 two-drug combinations across 125 molecularly characterized breast, colorectal & pancreatic cancer cell lines reveals that synergy is rare & highly context-dependent; combinations of targeted agents were most likely to be synergistic: https://t.co/UlNlHMOa0n
Thank you @barncancerfond for supporting my part in this fantastic team acheivement towards developing new anti-cancer drugs. Teamwork maks the dream work!
https://t.co/N72aakpwOS
The December edition of the #JITC Reading List is out. JITC’s Co-Section Editor, Dr. Melief, selects articles that add value to what readers find in the Journal for ImmunoTherapy of Cancer. Enjoy articles from the cancer #immunotherapy field https://t.co/YP2u2blb1R
Researchers at @masseyeandear have developed a blood test for HPV-related head and neck cancer associated that was shown to be more accurate, faster and cheaper than conventional testing methods. Read more >> https://t.co/MZRAXPul0o
The Tumor Independent Antigen concept, invented by @Immunicum, could benefit from PCI Biotech’s antigen delivery technologies based on Photochemical Internalization. https://t.co/VtdQmzDIo5
We are beyond excited to share our most recent paper published in @CCR today: Our study adds further evidence that brain tumors are in principle accessible to neoepitope-driven cell therapy. Big thanks to all our collaborators 🙏 Check it out! 👇
https://t.co/sk3wdn2PO4
Promising data for anti-PDL1 plus chemotherapy in pleural mesothelioma. Better outcome also correlated with broader TCR diversity.
https://t.co/Jl0SYG2KlC
In a first-in-human phase I trial of patients with advanced #lungcancer, #Tcells that were #CRISPR-edited to delete the PD-1 gene were well-tolerated and did not lead to severe treatment-related adverse events #immunotherapy#LungCancerAwarenessMonth https://t.co/pNWZgV7zt7
Light responsive platforms for controlled drug delivery webinar on Nov. 8 @ 9:30am US ET/ 3:30pm CET. Part of the IPA enlightenment series. Free registration
Speakers are Drs. David Lawrence, @pkselbo, & Jorg Trojan. Moderated by
@AnneBulin@pilar_acedo
https://t.co/Ig1ftGKRyH
All our favourite topics combined in one review: DSB repair, BRCA1 and R-loops. Interested too? Check out our recent review: https://t.co/T6h9NzJPcn. Great work of postdoc @MartaSanMartnA1!
Postdoc positions available in my lab to study the causes and consequences of replication stress, from R-loops to reversed forks! Join us in an exciting and collaborative environment at Stanford University. Message me. Please RT.
Thank Dr. Patrick Sung to tell us the fine regulation of BRCA2 in HR. This week, Simon will enlighten us on the end-protection mechanism. Pl note the new webinar sign up link from March 1st, 2021, and sign up on the current and future webinars at https://t.co/q9gUMA4WR2
Inspirerande! En miljardär lottar ut en plats på en rymdresa, för att samla in pengar till barncancerforskning. Tyvärr endast för amerikanska medborgare, så nu väntar vi på kreativa idéer från svenska miljardärer. Någon som är sugen? 😉
https://t.co/Vc4qDiswPp
Interested in #genome maintenance and #microscopy? Then look here: https://t.co/8bxhsNbWFM. Lukas group is seeking two #postdocs to join the pursuit of understanding how cells deal with heritable DNA and chromatin damage.